Insights
white paper
Antibody-based drug discovery at the speed of light
The combination of the PentaMice® platform and single B cell screening with the Berkeley Lights Beacon® Optofluidic system increases speed to market for monoclonal antibody therapeutics.
white paper
The benefits of end-to-end formulation and fill-finish of biologics
The clinical value of biologics for the treatment of many disease indications has been accompanied by phenomenal sales. By 2026, the global market for biologics is projected to increase to $537 billion. However, getting a promising drug candidate fro...
article
CMC Best Practices: Expediting Orphan Drug Development to Combat Rare Disease
February 28 marks the global observance of Rare Disease Day, a day when we participate in raising awareness and generating change for the global population and their families living with rare diseases.
article
Blog: How T3P has provided the catalyst to a new area of pharmaceutical research
A conversation with Lee J. Silverberg, Ph.D. Associate Professor of Chemistry, Pennsylvania State University
fact sheet
Comprehensive mRNA Solutions
Partner with Curia for combined expertise, speed and reliability to support the research, development and manufacturing of your mRNA product.
article
Blog: How T3P can enable greener, cost-effective peptide synthesis
Peptide-based pharmaceuticals have been growing in popularity in recent years, but synthesizing these complex drugs presents expensive environmental challenges.
infographic
Curia's Recently Filed DMFs
We offer a robust portfolio of market-leading APIs and world-class capabilities in niche and high-barrier-to-entry technologies.
article
The M.O. Behind Choosing a CDMO: Three Considerations for New Drug Developers
For many who are new to drug development, the greatest challenge is not necessarily discovering a blockbuster molecule—it’s finding a team capable of carrying that molecule through the complexities that lie between the research lab and the patien...
article
Rapid Drug Manufacturing Scale-Up: Best Practices
As pandemic conditions persist, the pharma industry continues to respond as rapidly as possible to bring more vaccine options to the global population. But developing one or more effective vaccines was just the first hurdle to clear. The drug industr...
webinar
Get the Most From Pharmaceutical X-ray Powder Diffraction Data Using Indexing
Watch this webinar to learn why indexing is a useful tool to glean additional information from X-ray powder diffraction data. The expert speaker will discuss the applications of indexing, including demonstrating pure crystalline phase identification...
publications patents
A Year In Review — Curia's Contributions to Science in 2020
The following research articles appeared in peer-reviewed scientific journals that described innovations conceived by Curia scientists. In most of these cases, these manuscripts were written by Curia lead authors to communicate independent research...
webinar
Casual Nexus – Episode Six: Biocatalysis, Biosynthesis and Fermentation - The Evolution of Chemistry via Biology
Presented by Pete Michels, Ph.D., Head of Global Fermentation, Curia Jose Luis Barredo, Ph.D., Director, Engineering Services, Curia Listen in as our experts discuss: A brief history of biocatalysis with a look at its current and futur...